Repligen to acquire BioLife Solutions for $11.25 cash plus stock
BioLife Solutions agreed to be acquired by Repligen for $11.25 cash and 0.1442 shares of Repligen stock per BioLife share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.